DrugDashboards

THIAMINE HYDROCHLORIDE injection, solution

THIAMINE HYDROCHLORIDE injection, solution · THIAMINE HYDROCHLORIDE 100 mg/mL · Injection, Solution · Intramuscular; Intravenous · HF Acquisition Co LLC, DBA HealthFirst

NDC 51662-1635-03 · 25 POUCH in 1 CASE / 1 VIAL, MULTI-DOSE in 1 POUCH / 2 mL in 1 VIAL, MULTI-DOSE · ANDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles. Historically, drugs in this position went on to a new shortage within 90 days about 0.4% of the time — roughly 3× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.4%chance of a new FDA shortage posting for thiamine hydrochloride (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 3× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA080571
TE code
AP
Approval date
Jan 1, 1982
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of THIAMINE HYDROCHLORIDE injection, solution (Injection, Solution)

LabelerStrengthFirst seenLast seen
HF Acquisition Co LLC, DBA HealthFirstTHIAMINE HYDROCHLORIDE 100 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "THIAMINE HYDROCHLORIDE injection, solution — NDC 51662-1635-03," retrieved September 3, 2026, https://drugdashboards.com/drug/51662163503.

Free to cite with attribution — see how the data is put together.